Therapeutic use of proanthocyanidine A2 as a cytoprotective agen

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514926, 514927, A61K 3135

Patent

active

049258702

ABSTRACT:
There is described a process for preparing proanthocyanidine A2 by extraction from cortex or fruits of Aesculus hippocastanum and related species and its activity for stimulating healing processes, e.g. healing wounds and injuries of various origins, gastric and duodenal ulcers for modifying conditions of impaired capillary permeability and resistance and for obtaining an anti-lipid peroxidation effect.
There are also described pharmaceutical formulations suitable for use by topical and systemic routes.

REFERENCES:
patent: 4258055 (1981-03-01), Lietti et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic use of proanthocyanidine A2 as a cytoprotective agen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic use of proanthocyanidine A2 as a cytoprotective agen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of proanthocyanidine A2 as a cytoprotective agen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-621850

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.